Circadian Technologies is engaged in angiogenesis-based treatments for cancer. Focusing on a class of drug targets called Vascular Endothelial Growth Factors (VEGFs), the company seeks to develop truly novel therapies to extend and improve the lives of cancer sufferers. The … Continue reading →

InVivo Therapeutics is focused on developing and commercializing technologies for the treatment of spinal cord injuries (SCI). The company’s aim is to develop/commercialize biocompatible polymer scaffolding devices to treat acute spinal cord injuries; biocompatible hydrogel to treat acute spinal cord … Continue reading →

ImmunoCellular Therapeutics is a clinical-stage biotech company focused on the development of novel immune-based products for the treatment of cancer. The product candidate portfolio includes cellular immunotherapies targeting cancer and cancer stem cell antigens, peptide based immunotherapies targeting cancer stem … Continue reading →

Tvax Biomedical is a clinical stage drug development company advancing its novel targeted cell-based immunotherapy for the treatment of cancer. The company’s lead candidates, focused on treating brain and kidney cancer, are supported by positive phase 2 clinical data and … Continue reading →

Atossa Genetics is a healthcare company that focuses on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer in the United States. Its diagnostic tests include the ForeCYTE Breast Health Test; and the ArgusCYTE … Continue reading →

Repros Therapeutics is a development stage biopharmaceutical company focused on the development of oral small molecule drugs for major unmet medical needs in male and female health. The company’s current product pipeline includes Androxal®, in phase 2 trials for male … Continue reading →

Pressure BioSciences engages in the development and commercialization of pressure cycling technology (PCT), a patented, enabling technology platform with multiple applications in the life sciences sample preparation market. PBIO’s focus is on the development and sale of PCT-enhanced sample preparation … Continue reading →

Amarantus Bioscience is a development-stage biotech company focused on the discovery and development of therapeutic proteins and biologics for the treatment of Parkinson’s disease, traumatic brain injury (TBI) and other human diseases. The company owns the intellectual property rights to … Continue reading →

Aethlon Medical is a development stage medical device company focused on creating devices for the treatment of cancer, infectious diseases and other life-threatening conditions. The company’s Aethlon Hemopurifier is intended for the treatment of cancer, hepatitis-C virus, human immunodeficiency virus … Continue reading →

Medbox, through its subsidiary Prescription Vending Machines Inc., engages in developing a patented machine that dispenses medication to individuals based on biometric identification. The company’s flagship product is MedBox, an automated medicine dispensing machine that utilizes biometrics to identify users … Continue reading →